论文部分内容阅读
尼美舒利(nimesulide)是新型、特效的非甾体抗炎、解热、镇痛药,由国家医药管理局天津药物研究院研制,经卫生部批准上市,天津药物研究院有限责任公司独家生产。尼美舒利的药理作用与化学结构不同于其它非甾体抗炎药,其活性基团为磺酰基,而非一般非甾体抗炎药的羧酸基或烯醇酸基,从而使尼美舒利具有独特的药理作用。临床研究表明,每日口服200～400mg,对解除疼痛、发烧、类风湿性关节炎、骨关节炎、呼吸道炎症、耳鼻喉科疾病、软组织及口腔炎症、痛经、静脉炎、泌尿生殖系统疾病及手术后疼痛均比炎痛喜康、扑热息
Nimesulide is a new and special non-steroidal anti-inflammatory, antipyretic and analgesic drug developed by the State Drug Administration Tianjin Institute of Materia Medica and approved by the Ministry of Health. The Tianjin Institute of Materia Medica limited liability company exclusive produce. Nimesulide pharmacological effects and chemical structure is different from other non-steroidal anti-inflammatory drugs, the active group is sulfonyl, rather than the general non-steroidal anti-inflammatory drugs carboxylic acid or enolic acid, so that the Nepal Mesyril has a unique pharmacological effect. Clinical studies have shown that daily oral administration of 200 ~ 400mg, to relieve pain, fever, rheumatoid arthritis, osteoarthritis, respiratory inflammation, ENT diseases, soft tissue and oral inflammation, dysmenorrhea, phlebitis, genitourinary system diseases and Postoperative pain than flu pain, paracetamol